Picture of InspireMD logo

NSPR InspireMD News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

InspireMD Inc expected to post a loss of 15 cents a share - Earnings Preview

* InspireMD Inc  NSPR.OQ   NSPR.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 14 for the
period ending March 31 2024
    * The Tel Aviv-yafo Israel-based   company is expected to
report a
11.7% increase in revenue to $1.384 million from $1.24 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for InspireMD Inc is for a
loss
of 15 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for InspireMD
Inc is
$4.50​, above​ its last closing price of $2.21. ​​​

This summary was machine generated May 10 at 12:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on InspireMD

See all news